AOD-9604vsFOXO4-DRI
AOD-9604 vs FOXO4-DRI — independent comparison of uses, administration, pricing across providers, and key differences. Last reviewed April 21, 2026.
Quick Verdict
Based on clinical evidence and real patient data
A modified fragment (amino acids 176-191) of human growth hormone designed to stimulate fat metabolism without the growth-promoting effects of full HGH. Studied as a targeted fat-loss peptide.
A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zombie cells.' A first-in-class senolytic peptide with potential to clear senescent cell burden.
Best choice depends on your insurance, budget, and treatment history.Take the quiz to get a personalized recommendation.
AOD-9604 vs FOXO4-DRI: At a Glance
Full comparison across all key factors.
| Factor | AOD-9604ALLY PICK | FOXO4-DRI |
|---|---|---|
| Category | weight-loss | anti-aging |
| Also Known As | Anti-Obesity Drug 9604 | Senostatin, FOXO4-p53 DRI peptide |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Prescription | Required | Required |
| Providers | 4 providers✓ Better | 2 providers |
| Common Uses |
|
|
Data sourced from FDA prescribing information and peer-reviewed clinical trials. Prices reflect telehealth platform costs as of April 21, 2026. See our methodology.
Pricing by Provider
2 providers offer both AOD-9604 and FOXO4-DRI.
| Provider | AOD-9604 | FOXO4-DRI | Consultation | Lab Testing |
|---|---|---|---|---|
 | $160/monthly | $450/per-cycle | Video Telehealth | Yes |
 | $220/monthly | $550/per-cycle | Video Telehealth | Yes |
 | $185/monthly | Not offered | Video Telehealth | Yes |
 | $150/monthly | Not offered | Video Telehealth | No |
Key Differences
AOD-9604
More ProvidersA modified fragment (amino acids 176-191) of human growth hormone designed to stimulate fat metabolism without the growth-promoting effects of full HGH. Studied as a targeted fat-loss peptide.
FOXO4-DRI
A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zombie cells.' A first-in-class senolytic peptide with potential to clear senescent cell burden.
Which Is Right for You?
Choose AOD-9604if…
- You want a weight-loss medication
- You prefer subcutaneous injection administration
- You want more provider options (4 available)
- Your primary goal is fat metabolism
- Your primary goal is body composition
Choose FOXO4-DRIif…
- You want a anti-aging medication
- You prefer subcutaneous injection administration
- 2 providers available on our platform
- Your primary goal is senescent cell clearance
- Your primary goal is tissue rejuvenation
Frequently Asked Questions
What is the difference between AOD-9604 and FOXO4-DRI?
Which is cheaper, AOD-9604 or FOXO4-DRI?
Can I switch from AOD-9604 to FOXO4-DRI?
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary. The information presented reflects publicly available data and may not account for your specific health situation.